-
2
-
-
0031004061
-
Medicinal applications of delta-9-tetrahydrocannabinol and marijuana
-
Voth, EA, Schwartz, RH. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med 1997; 126: 791-8.
-
(1997)
Ann Intern Med
, vol.126
, pp. 791-798
-
-
Voth, E.A.1
Schwartz, R.H.2
-
3
-
-
7244240550
-
Cannabinoid hyperemesis: Cyclical hyperemesis in association with chronic cannabis abuse
-
Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53: 1566-1570.
-
(2004)
Gut
, vol.53
, pp. 1566-1570
-
-
Allen, J.H.1
de Moore, G.M.2
Heddle, R.3
Twartz, J.C.4
-
4
-
-
0035822323
-
Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review
-
Tramer MR, Carroll D, Campbell FA, Reynolds JM, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323: 16-21
-
(2001)
BMJ
, vol.323
, pp. 16-21
-
-
Tramer, M.R.1
Carroll, D.2
Campbell, F.A.3
Reynolds, J.M.4
Moore, R.A.5
McQuay, H.J.6
-
5
-
-
46049119745
-
Adverse effects of medical cannabinoids: A systematic review
-
Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ 2008; 178: 1669-78
-
(2008)
CMAJ
, vol.178
, pp. 1669-1678
-
-
Wang, T.1
Collet, J.P.2
Shapiro, S.3
Ware, M.A.4
-
6
-
-
12344262003
-
Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptosis parva)
-
Darmani NA, Crim JL. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptosis parva). Pharmacol Biochem Behav 2005; 80: 35-44.
-
(2005)
Pharmacol Biochem Behav
, vol.80
, pp. 35-44
-
-
Darmani, N.A.1
Crim, J.L.2
-
7
-
-
65649093999
-
Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse
-
Sontineni PS, Chaundhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol 2009; 15: 1264-1266.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 1264-1266
-
-
Sontineni, P.S.1
Chaundhary, S.2
Sontineni, V.3
Lanspa, S.J.4
-
8
-
-
78649898843
-
Cannabinoid hyperemesis and compulsive bathing: A case series and paradoxical pathophysiological explanation
-
Patterson DA, Smith E, Monahan M, Medvecz A, Hagerty B, Krijger L, et al. Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation. J Am Board Fam Med 2010; 23: 790-793.
-
(2010)
J Am Board Fam Med
, vol.23
, pp. 790-793
-
-
Patterson, D.A.1
Smith, E.2
Monahan, M.3
Medvecz, A.4
Hagerty, B.5
Krijger, L.6
-
9
-
-
43049125139
-
Kanabinoidi-njihovo delovanje in učinki
-
Štempelj M, Ferjan I. Kanabinoidi-njihovo delovanje in učinki. Farm vestn; 2006; 57: 30-3.
-
(2006)
Farm vestn;
, vol.57
, pp. 30-33
-
-
Štempelj, M.1
Ferjan, I.2
-
10
-
-
60349123537
-
Cannabinoid hyperemesis relieved by compulsing bathing
-
Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsing bathing. Mayo Clin Proc 2009; 84: 76-8.
-
(2009)
Mayo Clin Proc
, vol.84
, pp. 76-78
-
-
Chang, Y.H.1
Windish, D.M.2
-
11
-
-
77955702652
-
Cannabinoid-induced hyperemesis: A conundrum from clinical recognition to basic science mechanisms
-
Darmani NA. Cannabinoid-induced hyperemesis: a conundrum from clinical recognition to basic science mechanisms. Pharmaceuticals 2010; 3: 2163-77.
-
(2010)
Pharmaceuticals
, vol.3
, pp. 2163-2177
-
-
Darmani, N.A.1
|